Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Photo not available

Jianqiao Zhang, Ph.D.

Associate Chief, Agreement Coordination Group
Regulatory Affairs Branch
240-276-6126
|
zhangjia@mail.nih.gov

Dr. Jianqiao Zhang is Associate Chief of the Agreement Coordination Group in CTEP’s Regulatory Affairs Branch (RAB). At RAB, Dr. Zhang’s responsibilities include setting up research and development agreements, such as CRADAs between the NCI and pharmaceutical companies on anti-cancer drug development. He also sets up collaboration agreements between NCI and diagnostic companies that are engaged in cancer biomarker assays. He also provides support for NCI funded National Clinical Trial Network (NCTN) groups and the Experimental Therapeutics Clinical Trials Network (ETCTN) on their agreements with pharmaceutical companies and diagnostic companies. He advises pharmaceutical companies, diagnostic companies, NCI network groups, NCI grantees, CTEP staff, and contractors on technology transfer, intellectual property, clinical research regulations, and NIH and NCI policies related to collaborations. Dr. Zhang has a Ph.D. in Biochemistry. 

Email